$0.1415
-0.0107-7.03%
Last update: Nov 5, 4:45 PM
VivoSim Labs Inc (VIVS) Stock Price, Quote, News & History
VIVSNASDAQ
VivoSim Labs (VIVS) stock plunges over 25% on a $4M private placement priced at $0.85/share. Read about the dilutive offering.
You can purchase shares of VivoSim Labs (NASDAQ:VIVS) through any online brokerage.
Other companies in VivoSim Labs’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
There is no analysis for VivoSim Labs to provide a consensus price target.
The stock price for VivoSim Labs (NASDAQ: VIVS) is $0.14 last updated November 5, 2026 at 4:45 PM EST.
There are no upcoming dividends for VivoSim Labs.
VivoSim Labs does not have any upcoming earnings scheduled.
There is no upcoming split for VivoSim Labs.
VivoSim Labs is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
VivoSim Labs Inc is a pharmaceutical and biotechnology services company focused on testing drugs and drug candidates in three-dimensional human tissue models of the liver and intestine. The Company provides liver and intestinal toxicology insights...
